JPWO2006062063A1 - Piperidine derivatives and process for producing the same - Google Patents

Piperidine derivatives and process for producing the same Download PDF

Info

Publication number
JPWO2006062063A1
JPWO2006062063A1 JP2006546678A JP2006546678A JPWO2006062063A1 JP WO2006062063 A1 JPWO2006062063 A1 JP WO2006062063A1 JP 2006546678 A JP2006546678 A JP 2006546678A JP 2006546678 A JP2006546678 A JP 2006546678A JP WO2006062063 A1 JPWO2006062063 A1 JP WO2006062063A1
Authority
JP
Japan
Prior art keywords
compound
acid
formula
reaction
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006546678A
Other languages
Japanese (ja)
Inventor
俊之 杉森
俊之 杉森
邦幸 佐野
邦幸 佐野
孝輔 米ノ井
孝輔 米ノ井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of JPWO2006062063A1 publication Critical patent/JPWO2006062063A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

式(I)で示されるピペリジン誘導体又はその塩を中間体として採用することにより、医薬、殊にDPP-IV阻害剤として有用な2-シアノ-4-フルオロピロリジン誘導体を効率よく製造することができる。特に、該中間体の採用により、公知の製造法と比べて総工程数を減じることができ、かつ全収率が向上する。また、工業的生産に適さない、極低温反応や反応系中の水分管理を厳密に行う必要のある反応を用いずに2-シアノ-4-フルオロピロリジン誘導体を製造することができる。[式中、Msはメタンスルホニル、Meはメチル、R1は-H、ハロゲン又は-OHを示す。]By employing a piperidine derivative represented by the formula (I) or a salt thereof as an intermediate, a 2-cyano-4-fluoropyrrolidine derivative useful as a pharmaceutical, particularly a DPP-IV inhibitor, can be efficiently produced. . In particular, by employing the intermediate, the total number of steps can be reduced as compared with known production methods, and the overall yield is improved. Further, the 2-cyano-4-fluoropyrrolidine derivative can be produced without using a cryogenic reaction that is not suitable for industrial production or a reaction that requires strict water management in the reaction system. [Wherein, Ms represents methanesulfonyl, Me represents methyl, R1 represents —H, halogen, or —OH. ]

Description

本発明は、医薬、殊にジペプチジルペプチダーゼ-IV(以下、DPP-IVと言う。)阻害剤として知られる、2-シアノ-4-フルオロピロリジン誘導体の製造法、及びその中間体、並びに該中間体の製造法に関する。   The present invention relates to a process for producing 2-cyano-4-fluoropyrrolidine derivatives known as pharmaceuticals, particularly dipeptidyl peptidase-IV (hereinafter referred to as DPP-IV) inhibitors, and intermediates thereof, and intermediates thereof. It relates to the manufacturing method of the body.

下記式(IV)で示される、4-フルオロ-1-({[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アミノ}アセチル)ピロリジン-2-カルボニトリル(以下、化合物Aと言う。)は、DPP-IV阻害剤として知られる化合物であり(特許文献1)、1型糖尿病、2型糖尿病、インスリン抵抗性疾患及び肥満等の治療及び/又は予防に有用な化合物であることが知られている。

Figure 2006062063
4-fluoro-1-({[4-methyl-1- (methanesulfonyl) piperidin-4-yl] amino} acetyl) pyrrolidine-2-carbonitrile represented by the following formula (IV) (hereinafter referred to as Compound A) Is a compound known as a DPP-IV inhibitor (Patent Document 1) and is a compound useful for the treatment and / or prevention of type 1 diabetes, type 2 diabetes, insulin resistance disease, obesity and the like. It has been known.
Figure 2006062063

化合物Aについては、4-メチル-1-(メタンスルホニル)ピペリジン-4-アミン(以下、化合物Bと言う。)若しくはその塩酸塩を原料化合物とした、以下の製造法Xが具体的に知られている(特許文献1)。   Regarding Compound A, the following production method X using 4-methyl-1- (methanesulfonyl) piperidin-4-amine (hereinafter referred to as Compound B) or its hydrochloride as a raw material compound is specifically known. (Patent Document 1).

(a)化合物Aの製造法「製造法X」

Figure 2006062063
[式中、Msはメタンスルホニルを、Meはメチルを示す。以下同様。](A) Compound A Production Method “Production Method X”
Figure 2006062063
[Wherein, Ms represents methanesulfonyl, and Me represents methyl. The same applies hereinafter. ]

また、製造法Xにおける原料化合物である化合物B若しくはその塩酸塩は、以下の製造法Y若しくは製造法Zで製造されることが知られている(特許文献1)。   Further, it is known that Compound B or its hydrochloride, which is a raw material compound in Production Method X, is produced by the following Production Method Y or Production Method Z (Patent Document 1).

(b)化合物Bの塩酸塩の製造法「製造法Y」

Figure 2006062063
[式中、Bocはtert-ブチルオキシカルボニルを、Et3Nはトリエチルアミンを、MsClはメタンスルホニルクロリドを、CH2Cl2は塩化メチレンを、DMFはN,N-ジメチルホルムアミドを、4M HCl-EtOAcは4 mol/L塩酸の酢酸エチル溶液を、EtOAcは酢酸エチルを示す。以下同様。](B) Production Method “Production Method Y” of Compound B Hydrochloride
Figure 2006062063
[Where Boc is tert-butyloxycarbonyl, Et 3 N is triethylamine, MsCl is methanesulfonyl chloride, CH 2 Cl 2 is methylene chloride, DMF is N, N-dimethylformamide, 4M HCl-EtOAc Indicates 4 mol / L hydrochloric acid in ethyl acetate, and EtOAc indicates ethyl acetate. The same applies hereinafter. ]

(c)化合物Bの製造法「製造法Z」

Figure 2006062063
[式中、Cbzはベンジルオキシカルボニルを、10% Pd/Cは10%パラジウム担持炭素を、MeOHはメタノールを示す。以下同様。](C) Production method “Production method Z” of compound B
Figure 2006062063
[Wherein Cbz represents benzyloxycarbonyl, 10% Pd / C represents 10% palladium-supported carbon, and MeOH represents methanol. The same applies hereinafter. ]

但し、上記製造法Y及び製造法Zで使用される原料化合物は、公知化合物ではあるが、商業的に安価かつ容易に入手できる化合物ではなく、これらの原料化合物を入手するためには、以下の公知の製造法で別途製造する必要があり、その製造工程は以下の通りである。   However, although the raw material compounds used in the above production method Y and production method Z are known compounds, they are not commercially cheap and easily obtainable compounds. In order to obtain these raw material compounds, the following compounds are used. It is necessary to manufacture separately with a well-known manufacturing method, and the manufacturing process is as follows.

(d)化合物Y-1の製造法(特許文献2、非特許文献1、非特許文献2)

Figure 2006062063
[式中、Bnはベンジルを、BnNH2はベンジルアミンを、Acはアセチルを示す。以下同様。](D) Production method of compound Y-1 (Patent Document 2, Non-Patent Document 1, Non-Patent Document 2)
Figure 2006062063
[Wherein, Bn represents benzyl, BnNH 2 represents benzylamine, and Ac represents acetyl. The same applies hereinafter. ]

(e)化合物Z-1の製造法(特許文献3)

Figure 2006062063
[式中、CO2Etはエトキシカルボニルを示す。以下同様。](E) Production method of compound Z-1 (Patent Document 3)
Figure 2006062063
[Wherein, CO 2 Et represents ethoxycarbonyl. The same applies hereinafter. ]

即ち、化合物Aを製造するに当たっての有用な中間体である化合物Bを、安価で入手容易な化合物を出発原料として製造するには、以下に示す(A)、(B)又は(C)の方法で製造する必要があり、それぞれの方法における総工程数及び全収率は以下に示すとおりである。
(A)Y-8を出発原料として、Y-5及びY-1を経由し、B又はその塩を製造する方法
総工程数:9工程
全収率:全9工程のうち、先行技術文献の記載から具体的に収率が導けるのは4工程であるが、この4工程だけでも通算収率は30.0%であり、残る具体的収率が不明の5工程を含めれば30.0%以下であることは明らかである。
(B)Y-9を出発原料として、Y-5及びY-1を経由し、B又はその塩を製造する方法
総工程数:7工程
全収率:全7工程のうち、先行技術文献の記載から具体的に収率が導けるのは5工程であるが、この5工程だけでも通算収率は17.7%であり、残る具体的収率が不明の2工程を含めれば17.7%以下であることは明らかである。
(C)Z-6を出発原料とし、Z-1を経由し、B又はその塩を製造する方法
総工程数:7工程
全収率:全7工程のうち、先行技術文献の記載から具体的に収率が導けるのは4工程であるが、この4工程だけでも通算収率は47.6%であり、残る具体的収率が不明の3工程を含めれば47.6%以下であることは明らかである。
That is, the following method (A), (B) or (C) is used to produce compound B, which is a useful intermediate in producing compound A, using a cheap and readily available compound as a starting material. The total number of steps and the total yield in each method are as shown below.
(A) Method for producing B or a salt thereof via Y-5 and Y-1 using Y-8 as a starting material Total number of steps: 9 steps Total yield: Of all 9 steps, The yield can be specifically derived from the four steps from the description, but the total yield is 30.0% even if only these four steps are included, and if the remaining five specific steps are not included, it should be 30.0% or less. Is clear.
(B) Method for producing B or a salt thereof via Y-5 and Y-1 using Y-9 as a starting material Total number of steps: 7 steps Total yield: Of all 7 steps, The yield can be specifically derived from the five steps from the description, but the total yield is 17.7% even if only these five steps are included, and if the remaining two specific steps are unknown, it is 17.7% or less. Is clear.
(C) Method for producing B or a salt thereof via Z-1 using Z-6 as a starting material Total number of steps: 7 steps Total yield: Of all 7 steps, specific from the description in the prior art document The yield can be derived in 4 steps, but the total yield is 47.6% even with these 4 steps alone, and it is clear that it is 47.6% or less if the remaining 3 specific steps are unknown. .

国際公開第WO 2004/009544号パンフレットInternational Publication No. WO 2004/009544 Pamphlet 特許出願公開特開平7-165754号公報Japanese Patent Application Publication No. 7-165754 国際公開第WO 99/40070号パンフレットInternational Publication No. WO 99/40070 pamphlet ジャーナル・オブ・アメリカン・ケミカル・ソサイエティ(Journal of American Chemical Society)、1985年、第107巻、pp.1768-1769Journal of American Chemical Society, 1985, 107, pp. 1768-1769 テトラへドロン(Tetrahedron)、1970年、第26巻、pp.5519-5527Tetrahedron, 1970, Volume 26, pp.5519-5527

従って、工業生産上、安価で入手容易な化合物を出発原料として、より総工程数の短縮された、かつ全収率の向上した化合物B又はその塩の製造法の開発が望まれていた。   Accordingly, it has been desired to develop a method for producing Compound B or a salt thereof with a reduced total number of steps and an improved overall yield, starting from an inexpensive and readily available compound for industrial production.

本発明者らは、DPP-IV阻害薬として、1型糖尿病、2型糖尿病、インスリン抵抗性疾患、及び肥満の治療及び/又は予防に有用な化合物Aの別途製造法について鋭意検討した結果、以下に示す製造法1及び製造法2の方法により、化合物Aを効率よく製造できることを見出し、本発明を完成させた。   As a result of diligent investigation on a method for separately producing Compound A useful for the treatment and / or prevention of type 1 diabetes, type 2 diabetes, insulin resistance disease, and obesity as DPP-IV inhibitors, It was found that the compound A can be efficiently produced by the production method 1 and the production method 2 shown in the following, and the present invention was completed.

即ち、本発明によれば、後述する製造法2に示す化合物Aの製造法を採用するに当たり、有用な中間体となる下記式(I)で示されるピペリジン誘導体又はその塩が提供される。   That is, according to the present invention, a piperidine derivative represented by the following formula (I) or a salt thereof, which is a useful intermediate when employing the production method of Compound A shown in Production Method 2 described later, is provided.

Figure 2006062063
[式中、R1は-H、ハロゲン又は-OHを示す。]
なお、R1として好ましくはハロゲンであり;さらに好ましくはクロロ又はブロモである。
Figure 2006062063
[Wherein, R 1 represents —H, halogen or —OH. ]
R 1 is preferably halogen; more preferably chloro or bromo.

また、上記式(I)で示されるピペリジン誘導体又はその塩から、R1を有するアセチル基を脱離させることを含む、式(II)で示される化合物Bの製造法が提供される。

Figure 2006062063
なお、この製造法において、R1を有するアセチル基を脱離させる反応としては、酸を用いた加水分解反応が好ましく、その中でも塩酸、臭化水素酸、トリフルオロ酢酸、硫酸、メタンスルホン酸、並びにp-トルエンスルホン酸及びその水和物からなる群より選択される1種若しくは2種以上の酸を用いた加水分解反応が好ましい。Also provided is a method for producing compound B represented by formula (II), which comprises removing an acetyl group having R 1 from a piperidine derivative represented by the above formula (I) or a salt thereof.
Figure 2006062063
In this production method, the reaction for removing the acetyl group having R 1 is preferably a hydrolysis reaction using an acid, among which hydrochloric acid, hydrobromic acid, trifluoroacetic acid, sulfuric acid, methanesulfonic acid, In addition, a hydrolysis reaction using one or more acids selected from the group consisting of p-toluenesulfonic acid and hydrates thereof is preferable.

また、式(III)で示される4-ヒドロキシピペリジン誘導体又はその塩を用いた、本発明化合物である式(I)で示されるピペリジン誘導体又はその塩の製造法が提供される。

Figure 2006062063
なお、この製造法において適用される反応としては、クロロアセトニトリル、ブロモアセトニトリル、アセトニトリル、シアン化水素及びグリコロニトリルからなる群より選択されるシアノ基を有する化合物を、酸性条件下に作用させる反応を用いることが好ましく、特にクロロアセトニトリル、ブロモアセトニトリル及びアセトニトリルからなる群より選択されるアセトニトリル誘導体と式(III)の化合物を、メタンスルホン酸及び硫酸からなる群より選択される酸の存在下に反応させることが好ましい。Moreover, the manufacturing method of the piperidine derivative or its salt shown by the formula (I) which is this invention compound using the 4-hydroxy piperidine derivative or its salt shown by Formula (III) is provided.
Figure 2006062063
The reaction applied in this production method is a reaction in which a compound having a cyano group selected from the group consisting of chloroacetonitrile, bromoacetonitrile, acetonitrile, hydrogen cyanide and glycolonitrile is allowed to act under acidic conditions. In particular, an acetonitrile derivative selected from the group consisting of chloroacetonitrile, bromoacetonitrile and acetonitrile and a compound of formula (III) are reacted in the presence of an acid selected from the group consisting of methanesulfonic acid and sulfuric acid. preferable.

また、上記式(I)で示されるピペリジン誘導体又はその塩から、R1を有するアセチル基を脱離させることを含む製造法により製造された化合物Bを用いた、式(IV)で示される化合物Aの製造法が提供される。

Figure 2006062063
In addition, a compound represented by the formula (IV) using a compound B produced by a production method including removing an acetyl group having R 1 from a piperidine derivative represented by the above formula (I) or a salt thereof. A manufacturing method of A is provided.
Figure 2006062063

(1)製造法1

Figure 2006062063
(1) Production method 1
Figure 2006062063

本製造法は、式(III)で示される化合物を経由した、本発明化合物である式(I)で示される化合物の製造法である。
(第1工程)
本工程は、化合物1-2のアミノ基に対してメタンスルホニル基を付加させる工程である。
反応は、当業者にとって自明の方法、あるいはグリーン(Greene)及びウッツ(Wuts)著、「Protective Groups in Organic Synthesis(third edition)」に記載の方法で行うことができる。
なお、化合物1-1は国際公開第WO 98/57862号パンフレットに記載の方法で製造することもできる。
(第2工程)
本工程は、化合物1-1のカルボニル基に対してメチル基を付加させる工程である。
反応試剤としては、メチルマグネシウムクロリド、メチルマグネシウムブロミド等のメチルマグネシウムハライド、メチルリチウム、トリメチルアルミニウム、リチウムジメチルクープラート、メチルトリクロロチタニウム等を挙げることができる。また、メチルマグネシウムハライド、メチルリチウムを使用する際には、セリウムトリクロリド等の添加により、化合物1-1のエノール化を抑制し、収率の向上を期待することができる。反応は、使用する反応試剤によっても異なるが、トルエン、キシレン等の芳香族炭化水素類;エチルエーテル、イソプロピルエーテル、ジn-ブチルエーテル、テトラヒドロフラン(THF)、ジオキサン等のエーテル類;ジクロロメチレン、クロロホルム、ジクロロエタン、トリクロロエタン、四塩化炭素等のハロゲン化炭化水素類;又はこれらの混合溶媒等の反応に不活性な溶媒中、冷却下、冷却下乃至室温下又は室温下乃至加熱下に行うことができ、反応温度は反応条件に応じて適宜選択することができる。
(第3工程)
本工程は、化合物(III)に対してシアノ基を有する化合物を酸性条件下に付加させる工程である。
反応試剤としては、クロロアセトニトリル、ブロモアセトニトリル、アセトニトリル、シアン化水素、グリコロニトリルを挙げることができる。また、用いられる酸としては、メタンスルホン酸、p-トルエンスルホン酸等のスルホン酸若しくはその水和物;硫酸;トリフルオロ酢酸;過塩素酸;リン酸;ポリリン酸;ギ酸;三フッ化ホウ素エーテラート、トリメリルシリルトリフラート等のルイス酸を挙げることができる。反応は、使用する反応試剤によっても異なるが、無溶媒若しくは反応に不活性な溶媒中に行うことができ、反応に不活性な溶媒としては酢酸;無水酢酸;エーテル類;ヘキサン、ペンタン、ヘプタン等の脂肪族炭化水素類;ハロゲン化炭化水素類;ニトロベンゼン等を挙げることができる。反応温度は反応条件に応じて適宜選択することができるが、冷却下、冷却下乃至室温下又は室温下乃至加熱下に行うことができる。
This production method is a method for producing a compound represented by the formula (I), which is a compound of the present invention, via a compound represented by the formula (III).
(First step)
This step is a step of adding a methanesulfonyl group to the amino group of compound 1-2.
The reaction can be carried out by a method obvious to those skilled in the art or by the method described in “Protective Groups in Organic Synthesis (third edition)” by Greene and Wuts.
Compound 1-1 can also be produced by the method described in WO 98/57862 pamphlet.
(Second step)
This step is a step of adding a methyl group to the carbonyl group of compound 1-1.
Examples of the reaction reagent include methylmagnesium halides such as methylmagnesium chloride and methylmagnesium bromide, methyllithium, trimethylaluminum, lithium dimethylcouprate, and methyltrichlorotitanium. In addition, when methyl magnesium halide or methyl lithium is used, the addition of cerium trichloride or the like can suppress the enolization of compound 1-1 and can be expected to improve the yield. The reaction varies depending on the reaction reagent used, but aromatic hydrocarbons such as toluene and xylene; ethers such as ethyl ether, isopropyl ether, di-n-butyl ether, tetrahydrofuran (THF), and dioxane; dichloromethylene, chloroform, Halogenated hydrocarbons such as dichloroethane, trichloroethane, and carbon tetrachloride; or a solvent inert to the reaction such as a mixed solvent thereof, under cooling, under cooling to room temperature, or under room temperature to heating, The reaction temperature can be appropriately selected according to the reaction conditions.
(Third step)
This step is a step of adding a compound having a cyano group to compound (III) under acidic conditions.
Examples of the reaction reagent include chloroacetonitrile, bromoacetonitrile, acetonitrile, hydrogen cyanide, and glycolonitrile. Examples of acids used include sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid or hydrates thereof; sulfuric acid; trifluoroacetic acid; perchloric acid; phosphoric acid; polyphosphoric acid; formic acid; boron trifluoride etherate. And Lewis acids such as trimerylsilyl triflate. Although the reaction varies depending on the reaction reagent used, it can be carried out without solvent or in a solvent inert to the reaction. Examples of the solvent inert to the reaction include acetic acid; acetic anhydride; ethers; hexane, pentane, heptane, etc. Aliphatic hydrocarbons; halogenated hydrocarbons; nitrobenzene and the like. The reaction temperature can be appropriately selected depending on the reaction conditions, but can be performed under cooling, under cooling to room temperature, or under room temperature to heating.

(2)製造法2

Figure 2006062063
(2) Production method 2
Figure 2006062063

本製造法は、式(I)で示される本発明化合物を用いた、式(II)で示される化合物Bの製造法、及び式(IV)で示される化合物Aの製造法である。
(第1工程)
本工程は、本発明化合物(I)からR1を有するアセチル基を脱離させる工程である。
好ましくは酸を用いた加水分解反応を挙げることができるが、その酸としては、塩酸、臭化水素酸、トリフルオロ酢酸、硫酸、メタンスルホン酸、又はp-トルエンスルホン酸若しくはその水和物を挙げることができ、これらのうち1種の酸を使用することも、2種以上の酸を使用することもできる。反応は、化合物(I)におけるR1で示される基によっても異なるが、メタノール(MeOH)、エタノール(EtOH)、1-プロパノール、2-プロパノール(iPrOH)、1-ブタノール(nBuOH)等のアルコール類と水の混合溶媒中(なお、水は濃塩酸や硫酸等にもともと含まれる水分で代用することもできる)、冷却下、冷却下乃至室温下又は室温下乃至加熱下に行うことができ、反応温度は反応条件に応じて適宜選択することができる。
(第2工程)
本工程は、化合物(II)と、国際公開第WO 2004/009544号パンフレットに記載の方法、若しくはそれに準じた方法で製造される1-クロロアセチル-4-フルオロピロリジン-2-カルボニトリル、又はその類縁体(例えば、1-ブロモアセチル-4-フルオロピロリジン-2-カルボニトリルを挙げることができる。)とを縮合させる工程である。
塩基を添加したり、化合物(II)を過剰に用いることで有利に反応を進行させることができ、その塩基としては、トリエチルアミン、N-エチルジイソプロピルアミン、ピリジン等の有機塩基;炭酸カリウム、炭酸セシウム、炭酸水素ナトリウム、水酸化カリウム等の無機塩基を挙げることができる。反応は、化合物(II)に縮合させる化合物の反応性等によっても異なるが、無溶媒あるいは溶媒を用いて反応を行うことができ、用いられる溶媒としては、アセトニトリル、N,N-ジメチルホルムアミド、ジメチルスルホキシド、芳香族炭化水素類、エーテル類、アルコール類、ハロゲン化炭化水素類、メチルエチルケトンやアセトンのようなケトン類、水、あるいはこれらの混合溶媒を挙げることができる。反応は、冷却下、冷却下乃至室温下又は室温下乃至加熱下に行うことができ、反応温度は反応条件に応じて適宜選択することができる。
This production method is a production method of the compound B represented by the formula (II) and the production method of the compound A represented by the formula (IV) using the compound of the present invention represented by the formula (I).
(First step)
This step is a step of removing the acetyl group having R 1 from the compound (I) of the present invention.
Preferably, a hydrolysis reaction using an acid can be mentioned. Examples of the acid include hydrochloric acid, hydrobromic acid, trifluoroacetic acid, sulfuric acid, methanesulfonic acid, and p-toluenesulfonic acid or a hydrate thereof. Of these, one acid can be used, or two or more acids can be used. The reaction varies depending on the group represented by R 1 in compound (I), but alcohols such as methanol (MeOH), ethanol (EtOH), 1-propanol, 2-propanol (iPrOH), and 1-butanol (nBuOH) In a mixed solvent of water and water (in addition, water can be substituted with water originally contained in concentrated hydrochloric acid, sulfuric acid, etc.), under cooling, under cooling to room temperature or under room temperature to heating, The temperature can be appropriately selected according to the reaction conditions.
(Second step)
This step comprises compound (II), 1-chloroacetyl-4-fluoropyrrolidine-2-carbonitrile produced by the method described in International Publication No. WO 2004/009544 pamphlet, or a method analogous thereto, or its This is a step of condensing an analog (for example, 1-bromoacetyl-4-fluoropyrrolidine-2-carbonitrile).
The reaction can be advantageously carried out by adding a base or using an excess of compound (II). Examples of the base include organic bases such as triethylamine, N-ethyldiisopropylamine, and pyridine; potassium carbonate, cesium carbonate And inorganic bases such as sodium hydrogen carbonate and potassium hydroxide. The reaction varies depending on the reactivity of the compound to be condensed with the compound (II), but the reaction can be carried out without solvent or using a solvent. Examples of the solvent used include acetonitrile, N, N-dimethylformamide, dimethyl Examples thereof include sulfoxides, aromatic hydrocarbons, ethers, alcohols, halogenated hydrocarbons, ketones such as methyl ethyl ketone and acetone, water, and mixed solvents thereof. The reaction can be performed under cooling, under cooling to room temperature, or under room temperature to heating, and the reaction temperature can be appropriately selected according to the reaction conditions.

即ち、本発明の製造法によれば、安価でかつ入手容易な原料化合物であるピペリジン-4-オン塩酸塩水和物から、わずか4工程で化合物(II)を製造することができる。また、後述する実施例4乃至6に示すように、その全収率は43.7%である。
一方、化合物(II)を製造するに当たり、公知製造法においては上述の(A)、(B)及び(C)の通りである。総工程数の点では、公知製造法(A)では9工程、公知製造法(B)及び(C)では7工程必要であったものが、本発明の製造法によれば4工程で製造できる。この総工程数の短縮は、工業生産上、経済性や効率性、安定供給面等において非常に有利な効果をもたらすことはよく知られているところである。
また、全収率の点では、公知製造法(A)、(B)及び(C)にそれぞれ収率不明の工程があるが、公知製造法(A)では、収率不明の5つの工程の収率をすべて100%と仮定したとしても30.0%であり、公知製造法(B)では、収率不明の2つの工程の収率をすべて100%と仮定したとしても17.7%である。また、公知製造法(C)に関しては、収率不明の工程が3工程あるが、そのうち、Z-1からZ-0を製造する工程について3回の追試を行ったところ、その平均収率は68.7%であり、Z-0からBを製造する工程について2回の追試を行ったところ、その平均収率は98.5%であった。従って、公知製造法(C)の全収率に関して、これらの追試結果を加味すれば、いまだ収率不明の工程が1工程残るが、その工程の収率を100%と仮定したとしても、全収率は32.2%である。本発明の製造法の全収率が43.7%であることから、本発明の製造法は、公知製造法(A)、(B)及び(C)に対して、全収率が格段に向上したと言える。全収率の向上は、工業生産上、経済性や効率性、安定供給面からの有利な効果をもたらすことはよく知られているところである。
また、公知製造法(C)においては、ピペリジン4位のメチル基を導入するに当たり、リチウムジイソプロピルアミドを使用しているが、この試薬は非常に低い温度での反応を要求し、特許文献3においては-78 ℃もの低温を必要としている。工業的生産においては、このような非常に低い温度の制御は困難を伴うことが多く、経済性や効率性の面で工業的生産には適さない。さらに、公知製造法(C)においては、ピペリジン4位のカルボキシル基をベンジルオキシカルボニルアミノ基に変換するに当たり、いわゆるCurtius転移反応を使用しているが、この反応は反応系中で発生した中間体が水によって容易に分解するため、厳密に反応系中の水分管理を行う必要があり、工業的生産においては経済性や効率性の面で適さない反応である。
That is, according to the production method of the present invention, the compound (II) can be produced from piperidin-4-one hydrochloride hydrate, which is an inexpensive and easily available raw material compound, in only 4 steps. Further, as shown in Examples 4 to 6 described later, the total yield is 43.7%.
On the other hand, in producing compound (II), the known production methods are as described in (A), (B) and (C) above. In terms of the total number of steps, 9 steps were required in the known production method (A), and 7 steps were required in the known production methods (B) and (C), but according to the production method of the present invention, it can be produced in 4 steps. . It is well known that this reduction in the total number of processes brings very advantageous effects in terms of industrial production, such as economy and efficiency, and stable supply.
Moreover, in terms of the total yield, the known production methods (A), (B), and (C) each have a process whose yield is unknown, but in the known production process (A), there are five processes whose yield is unknown. Even if all the yields are assumed to be 100%, it is 30.0%. In the known production method (B), the yields of the two steps whose yields are unknown are all assumed to be 17.7%. In addition, with regard to the known production method (C), there are three steps with unknown yield. Of these, three additional tests were conducted on the step of producing Z-0 from Z-1, and the average yield was It was 68.7%, and when the process for producing B from Z-0 was conducted twice, the average yield was 98.5%. Therefore, with regard to the total yield of the known production method (C), if these additional test results are taken into consideration, one process with an unknown yield remains, but even if the yield of the process is assumed to be 100%, The yield is 32.2%. Since the overall yield of the production method of the present invention is 43.7%, the overall yield of the production method of the present invention is significantly improved over the known production methods (A), (B) and (C). It can be said. It is well known that the improvement of the overall yield brings about advantageous effects from the viewpoint of economic efficiency, efficiency, and stable supply in industrial production.
In addition, in the known production method (C), lithium diisopropylamide is used to introduce the methyl group at the 4-position of piperidine, but this reagent requires a reaction at a very low temperature. Needs as low as -78 ° C. In industrial production, it is often difficult to control such a very low temperature, which is not suitable for industrial production in terms of economy and efficiency. Furthermore, in the known production method (C), a so-called Curtius rearrangement reaction is used to convert the carboxyl group at the 4-position of piperidine into a benzyloxycarbonylamino group. This reaction is an intermediate generated in the reaction system. Since it is easily decomposed by water, it is necessary to strictly control the water content in the reaction system, and this reaction is not suitable in terms of economy and efficiency in industrial production.

従って、本発明の製造法は、公知の製造法と比較して、(1)総工程数が格段に短縮されている上、(2)全収率が格段に向上している点、及び(3)非常に低い温度を必要とする反応や、水分の存在により反応の進行が妨げられるおそれのある反応等の、工業的生産にあまり適さない反応を不要とし、工業的生産に適した反応のみで構成されている点で優れた製造法であり、非常に有用かつ簡便な製造法である。即ち、化合物(II)の製造、さらには化合物(IV)の製造に当たっては、本発明化合物(I)を製造中間体として採用することがきわめて有利であり、その効果は上述の通りである。   Therefore, the production method of the present invention has (1) the total number of steps is remarkably shortened and (2) the overall yield is greatly improved, compared with the known production methods, and ( 3) Reactions that require very low temperatures and reactions that are not suitable for industrial production, such as reactions that may hinder the progress of the reaction due to the presence of moisture, are unnecessary, and only reactions that are suitable for industrial production. It is an excellent production method in that it is constituted by, and is a very useful and simple production method. That is, in the production of compound (II), and further in the production of compound (IV), it is extremely advantageous to employ the compound (I) of the present invention as a production intermediate, and the effect is as described above.

本発明をさらに説明すると以下の通りである。
本明細書中、「ハロゲン」とはクロロ、ブロモ、ヨード、フルオロを挙げることができ、好ましくはクロロ若しくはブロモである。
また、「式(I)で示されるピペリジン誘導体又はその塩」、「式(II)で示される4-アミノピペリジン誘導体又はその塩」、「式(III)で示される4-ヒドロキシピペリジン誘導体又はその塩」又は「2-シアノ-4-フルオロピロリジン誘導体又はその塩」における塩とは、式(I)で示されるピペリジン誘導体、式(II)で示される4-アミノピペリジン誘導体、式(III)で示される4-ヒドロキシピペリジン誘導体、又は2-シアノ-4-フルオロピロリジン誘導体の酸付加塩を意味し、その酸としては、塩酸、臭化水素酸、ヨウ化水素酸、硫酸、硝酸、リン酸等の鉱酸;メタンスルホン酸、エタンスルホン酸、ベンゼンスルホン酸、トルエンスルホン酸、トリフルオロメタンスルホン酸等のスルホン酸;ギ酸、酢酸、プロピオン酸、シュウ酸、マロン酸、コハク酸、フマル酸、マレイン酸、乳酸、リンゴ酸、酒石酸、クエン酸等の有機酸;アスパラギン酸、グルタミン酸等の酸性アミノ酸;等を挙げることができる。また、「その塩」としては、それぞれの化合物及びその塩の、各種の水和物や溶媒和物及び結晶多形の物質をも包含する。
また、化合物(IV)は不斉炭素を有しているため、以下の4つの光学異性体が存在するが、好ましくは(IV−1)で示される(2S,4S)-体である。

Figure 2006062063
The present invention will be further described as follows.
In the present specification, “halogen” includes chloro, bromo, iodo and fluoro, preferably chloro or bromo.
Further, “a piperidine derivative represented by formula (I) or a salt thereof”, “a 4-aminopiperidine derivative represented by formula (II) or a salt thereof”, “a 4-hydroxypiperidine derivative represented by formula (III) or a salt thereof The salt in “salt” or “2-cyano-4-fluoropyrrolidine derivative or salt thereof” is a piperidine derivative represented by formula (I), a 4-aminopiperidine derivative represented by formula (II), or a formula (III) It means an acid addition salt of the 4-hydroxypiperidine derivative or 2-cyano-4-fluoropyrrolidine derivative shown, and the acid includes hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid, phosphoric acid, etc. Mineral acids of methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, trifluoromethanesulfonic acid and other sulfonic acids; formic acid, acetic acid, propionic acid, oxalic acid And the like can be given; aspartic acid, acidic amino acids glutamic acid and the like; malonic acid, succinic acid, fumaric acid, maleic acid, lactic acid, malic acid, tartaric acid, organic acids such as citric acid. The “salts” also include various hydrates, solvates and crystalline polymorphs of the respective compounds and salts thereof.
In addition, since compound (IV) has an asymmetric carbon, the following four optical isomers exist, and (2S, 4S) -form represented by (IV-1) is preferable.
Figure 2006062063

以下、実施例により本発明を具体的に説明するが、本発明はこれらの実施例により何ら制限されるものではない。   EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, this invention is not restrict | limited at all by these Examples.

実施例1
メチルマグネシウムクロリドの2 mol/LのTHF溶液847.0 gに4-[1-(メタンスルホニル)]ピペリドン150.0gをTHF 1950 mLに溶解した溶液を、10 ℃以下で攪拌しながら加え、THF 75 mLで洗いこんだ。4時間攪拌後、水75 mL、20%(w/v)塩化アンモニウム水溶液1000 mL、トルエン750 mLを加え、有機層を分液した。有機層を20%(w/v)食塩水900 mLで洗浄し、この液を減圧濃縮し、トルエン1050 mLを加え減圧濃縮を行う操作をさらに2回繰り返した。残さにトルエン450 mLを加え、80 ℃で加熱溶解した。攪拌下、0 ℃まで冷却し、析出した結晶を濾取し、トルエンで結晶を洗浄した後、減圧乾燥することにより、4-メチル-1-(メタンスルホニル)ピペリジン-4-オール127.1 gを白色結晶として得た。
1H-NMR(DMSO-d6):1.14(s,3H),1.47-1.58(m,4H),2.83(s,3H),3.00(dt,2H),3.25(dt,2H),4.37(s,1H).
FAB-MS m/z:194(M+1).
Example 1
A solution of 150.0 g of 4- [1- (methanesulfonyl)] piperidone in 1950 mL of THF in 847.0 g of a 2 mol / L THF solution of methylmagnesium chloride was added with stirring at 10 ° C. or less, and 75 mL of THF was added. I washed it in. After stirring for 4 hours, 75 mL of water, 1000 mL of 20% (w / v) ammonium chloride aqueous solution and 750 mL of toluene were added, and the organic layer was separated. The organic layer was washed with 900 mL of 20% (w / v) brine, this solution was concentrated under reduced pressure, and the operation of adding 1050 mL of toluene and concentrating under reduced pressure was repeated twice more. To the residue, 450 mL of toluene was added and dissolved by heating at 80 ° C. The mixture was cooled to 0 ° C. with stirring, and the precipitated crystals were collected by filtration, washed with toluene, and dried under reduced pressure to give 127.1 g of 4-methyl-1- (methanesulfonyl) piperidin-4-ol as white. Obtained as crystals.
1 H-NMR (DMSO-d 6 ): 1.14 (s, 3H), 1.47-1.58 (m, 4H), 2.83 (s, 3H), 3.00 (dt, 2H), 3.25 (dt, 2H), 4.37 ( s, 1H).
FAB-MS m / z: 194 (M + 1).

実施例2
メタンスルホン酸740.5 gに4-メチル-1-(メタンスルホニル)ピペリジン-4-オールを200.0 g加え、メタンスルホン酸148.1 gで洗いこんだ。得られた混合物にクロロアセトニトリル78.1 gを加え、室温下で一晩攪拌した。反応液に酢酸エチル(EtOAc)を1200 mL加え、27%(w/v)炭酸カリウム水溶液2700 mLへ攪拌しながら徐々に滴下した。有機層を分液し、10%(w/v)炭酸水素カリウム水溶液600 mL、水600 mLで洗浄した。溶媒を減圧下留去することにより、2-クロロ-N-[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アセトアミド264.7 gを淡黄色結晶として得た。
1H-NMR(CDCl3):1.45(s,3H),1.74-1.81(m,2H),2.25-2.29(m,2H),2.81(s,3H),2.97-3.04(m,2H),3.47-3.52(m,2H),4.00(s,2H),6.27(brs,1H).
FAB-MS m/z:269(M+1).
Example 2
200.0 g of 4-methyl-1- (methanesulfonyl) piperidin-4-ol was added to 740.5 g of methanesulfonic acid and washed with 148.1 g of methanesulfonic acid. To the obtained mixture, 78.1 g of chloroacetonitrile was added, and the mixture was stirred overnight at room temperature. To the reaction solution, 1200 mL of ethyl acetate (EtOAc) was added, and the mixture was gradually added dropwise to 2700 mL of 27% (w / v) aqueous potassium carbonate solution with stirring. The organic layer was separated and washed with 600 mL of 10% (w / v) aqueous potassium hydrogen carbonate solution and 600 mL of water. The solvent was distilled off under reduced pressure to obtain 264.7 g of 2-chloro-N- [4-methyl-1- (methanesulfonyl) piperidin-4-yl] acetamide as pale yellow crystals.
1 H-NMR (CDCl 3 ): 1.45 (s, 3H), 1.74-1.81 (m, 2H), 2.25-2.29 (m, 2H), 2.81 (s, 3H), 2.97-3.04 (m, 2H), 3.47-3.52 (m, 2H), 4.00 (s, 2H), 6.27 (brs, 1H).
FAB-MS m / z: 269 (M + 1).

実施例3
酢酸15 mLに4-メチル-1-(メタンスルホニル)ピペリジン-4-オールを10.00 g加え、10 ℃に冷却した。硫酸10 mL、クロロアセトニトリル5.08 gを20℃で攪拌しながら加え、その後9時間攪拌した。水150 mL、炭酸リチウム22.00 g、酢酸イソプロピル100 mLの混合液に反応液を35 ℃以下で加えた。有機層を分液し、水20 mLで洗浄し、溶媒を減圧下留去した。
2-クロロ-N-[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アセトアミドを含む濃縮残渣に水8 mL、濃塩酸8 mLを加え、100 ℃で24時間攪拌した。室温下冷却し、2-プロパノール50 mLを加え、結晶を析出させた。攪拌下、0 ℃まで冷却し、結晶を濾取し、2-プロパノールで結晶を洗浄した後、減圧乾燥することにより、4-メチル-1-(メタンスルホニル)ピペリジン-4-アミン 一塩酸塩 一水和物を白色結晶として得た。
Example 3
To 15 mL of acetic acid, 10.00 g of 4-methyl-1- (methanesulfonyl) piperidin-4-ol was added and cooled to 10 ° C. 10 mL of sulfuric acid and 5.08 g of chloroacetonitrile were added with stirring at 20 ° C., and then stirred for 9 hours. The reaction solution was added to a mixed solution of 150 mL of water, 22.00 g of lithium carbonate, and 100 mL of isopropyl acetate at 35 ° C. or lower. The organic layer was separated and washed with 20 mL of water, and the solvent was distilled off under reduced pressure.
To a concentrated residue containing 2-chloro-N- [4-methyl-1- (methanesulfonyl) piperidin-4-yl] acetamide were added 8 mL of water and 8 mL of concentrated hydrochloric acid, and the mixture was stirred at 100 ° C. for 24 hours. After cooling at room temperature, 50 mL of 2-propanol was added to precipitate crystals. The mixture was cooled to 0 ° C. with stirring, the crystals were collected by filtration, washed with 2-propanol, and dried under reduced pressure to give 4-methyl-1- (methanesulfonyl) piperidin-4-amine monohydrochloride monohydrochloride. Hydrates were obtained as white crystals.

実施例4
水2500 mLにピペリジン-4-オン 一塩酸塩一水和物500.0 g、炭酸カリウム674.8 g、アセトニトリル2400 mLを加え10 ℃以下に冷却した。メタンスルホニルクロリド559.3 gを35 ℃以下で攪拌しながら加え、アセトニトリル100 mLで洗いこんだ。24時間攪拌後、炭酸カリウム45.0 gを加えて中和し、トルエン2500 mLを加えて抽出した。水層を分液後、さらにアセトニトリル500 mL、トルエン1500 mLを加えて抽出した。有機層を混合し、減圧下、溶媒を留去した。さらにトルエンを2500 mL加え、減圧下溶媒を留去した。得られた残さにトルエンを2500 mL加え、85 ℃で加熱溶解した。攪拌下、0 ℃まで冷却し、析出した結晶を濾取し、トルエンで結晶を洗浄した後、減圧乾燥することにより、4-[1-(メタンスルホニル)]ピペリドン 488.7 g(収率84.7 %)を白色結晶として得た。
1H-NMR(DMSO-d6):2.46(t,4H),2.97(s,3H),3.49(t,4H).
FAB-MS m/z:178(M+1).
Example 4
Piperidin-4-one monohydrochloride monohydrate 500.0 g, potassium carbonate 674.8 g, and acetonitrile 2400 mL were added to 2500 mL of water, and the mixture was cooled to 10 ° C. or lower. Methanesulfonyl chloride (559.3 g) was added with stirring at 35 ° C. or lower and washed with 100 mL of acetonitrile. After stirring for 24 hours, 45.0 g of potassium carbonate was added for neutralization, and 2500 mL of toluene was added for extraction. The aqueous layer was separated, and further extracted with 500 mL of acetonitrile and 1500 mL of toluene. The organic layers were mixed and the solvent was distilled off under reduced pressure. Furthermore, 2500 mL of toluene was added, and the solvent was distilled off under reduced pressure. To the resulting residue, 2500 mL of toluene was added and dissolved by heating at 85 ° C. The mixture was cooled to 0 ° C. with stirring, and the precipitated crystals were collected by filtration, washed with toluene, and dried under reduced pressure to give 488.7 g of 4- [1- (methanesulfonyl)] piperidone (yield 84.7%) Was obtained as white crystals.
1 H-NMR (DMSO-d 6 ): 2.46 (t, 4H), 2.97 (s, 3H), 3.49 (t, 4H).
FAB-MS m / z: 178 (M + 1).

実施例5
メチルマグネシウムクロリドの1 mol/LのTHF溶液21.02 gに、4-[1-(メタンスルホニル)]ピペリドン2.00 gをTHF 26 mLに溶解した溶液を、10 ℃以下で攪拌しながら加え、THF 1 mLで洗いこんだ。室温で2時間攪拌後、水1 mL、20%(w/v)塩化アンモニウム水溶液13 mLを加え、有機層を分液した。有機層を20%(w/v)食塩水11 mLで洗浄した。この有機層を10 mLまで減圧濃縮し、トルエン14 mLを加え、全量が14 mLまで減圧濃縮を行う操作を4回繰り返した。析出した結晶を濾取し、減圧乾燥することにより、4-メチル-1-(メタンスルホニル)ピペリジン-4-オール1.84 g(収率84.4%)を白色結晶として得た。
Example 5
A solution of 2.00 g of 4- [1- (methanesulfonyl)] piperidone in 26 mL of THF was added to 21.02 g of a 1 mol / L THF solution of methylmagnesium chloride with stirring at 10 ° C. or less, and 1 mL of THF was added. I washed it in. After stirring at room temperature for 2 hours, 1 mL of water and 13 mL of 20% (w / v) aqueous ammonium chloride solution were added, and the organic layer was separated. The organic layer was washed with 11 mL of 20% (w / v) brine. This organic layer was concentrated under reduced pressure to 10 mL, 14 mL of toluene was added, and the operation of concentration under reduced pressure to a total volume of 14 mL was repeated 4 times. The precipitated crystals were collected by filtration and dried under reduced pressure to obtain 1.84 g (yield 84.4%) of 4-methyl-1- (methanesulfonyl) piperidin-4-ol as white crystals.

実施例6
酢酸15 mLに4-メチル-1-(メタンスルホニル)ピペリジン-4-オールを10.00 g加え、10 ℃に冷却した。硫酸10 mL、クロロアセトニトリル5.08 gを20 ℃以下で攪拌しながら加え、その後3日間攪拌した。水150 mL、炭酸リチウム21.00 g、酢酸イソプロピル100 mLの混合液に、反応液を30 ℃以下で加えた。有機層を分液し水20 mLで洗浄し、溶媒を減圧下留去した。
2-クロロ-N-[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アセトアミドを含む濃縮残さにnBuOH 60 mL、水10 mL、濃塩酸10 mLを加え100 ℃で13時間攪拌した。室温下冷却しiPrOH 200 mLを加えた。実施例3の白色結晶を接種して、結晶を析出させた後、攪拌下0 ℃まで冷却した。結晶を濾取し、iPrOHで結晶を洗浄した後、減圧乾燥することにより、4-メチル-1-(メタンスルホニル)ピペリジン-4-アミン 一塩酸塩 一水和物7.81 g(収率61.2 %)を白色結晶として得た。
Example 6
To 15 mL of acetic acid, 10.00 g of 4-methyl-1- (methanesulfonyl) piperidin-4-ol was added and cooled to 10 ° C. 10 mL of sulfuric acid and 5.08 g of chloroacetonitrile were added with stirring at 20 ° C. or lower, and then stirred for 3 days. The reaction solution was added to a mixed solution of 150 mL of water, 21.00 g of lithium carbonate, and 100 mL of isopropyl acetate at 30 ° C. or lower. The organic layer was separated and washed with 20 mL of water, and the solvent was distilled off under reduced pressure.
To the concentrated residue containing 2-chloro-N- [4-methyl-1- (methanesulfonyl) piperidin-4-yl] acetamide was added 60 mL of nBuOH, 10 mL of water, and 10 mL of concentrated hydrochloric acid, and the mixture was stirred at 100 ° C. for 13 hours. . After cooling at room temperature, 200 mL of iPrOH was added. The white crystals of Example 3 were inoculated to precipitate crystals, and then cooled to 0 ° C. with stirring. The crystals were collected by filtration, washed with iPrOH, and then dried under reduced pressure to give 7.81 g (yield 61.2%) of 4-methyl-1- (methanesulfonyl) piperidin-4-amine monohydrochloride monohydrate Was obtained as white crystals.

即ち、本発明化合物を製造中間体として採用し、本発明の製造法により化合物(II)を製造すれば、実施例4乃至6の結果から、安価でかつ入手容易な原料化合物であるピペリジン-4-オン塩酸塩水和物を出発原料とし、わずか4工程、全収率43.7%で化合物(II)を製造することができる。   That is, if the compound of the present invention is employed as a production intermediate and compound (II) is produced by the production method of the present invention, piperidine-4 which is an inexpensive and readily available starting compound is obtained from the results of Examples 4 to 6. Compound (II) can be produced with only 4 steps and an overall yield of 43.7%, starting from -one hydrochloride hydrate.

実施例7
4-メチル-1-(メタンスルホニル)ピペリジン-4-オール2.85 gにアセトニトリル8.5 mLを加え10 ℃以下に冷却した。硫酸5.7 mLを20 ℃以下で攪拌しながら加え、その後3時間攪拌した。反応液を氷冷水100 mLに注ぎ、炭酸ナトリウム12.7 gを加えて中和した。EtOAc 80 mL、EtOAc 50 mLでそれぞれ抽出し、有機層を減圧下濃縮し、溶媒を留去した。得られた残さをシリカゲルカラムクロマトグラフィー(クロロホルム:MeOH=50:1)で精製することにより、N-[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アセトアミド3.56 gを黄色油状物として得た。
1H-NMR(DMSO-d6):1.27(s,3H),1.45-1.52(m,2H),1.81(s,3H),2.15-2.18(m,2H),2.85(s,3H),2.88-2.97(m,2H),3.20-3.27(m,2H),7.36(brs,1H).
FAB-MS m/z:235(M+1).
Example 7
8.5 mL of acetonitrile was added to 2.85 g of 4-methyl-1- (methanesulfonyl) piperidin-4-ol and cooled to 10 ° C. or lower. 5.7 mL of sulfuric acid was added with stirring at 20 ° C. or lower, and then stirred for 3 hours. The reaction solution was poured into 100 mL of ice-cold water and neutralized by adding 12.7 g of sodium carbonate. Extraction was performed with 80 mL of EtOAc and 50 mL of EtOAc, the organic layer was concentrated under reduced pressure, and the solvent was distilled off. The obtained residue was purified by silica gel column chromatography (chloroform: MeOH = 50: 1) to give 3.56 g of N- [4-methyl-1- (methanesulfonyl) piperidin-4-yl] acetamide as a yellow oil Got as.
1 H-NMR (DMSO-d 6 ): 1.27 (s, 3H), 1.45-1.52 (m, 2H), 1.81 (s, 3H), 2.15-2.18 (m, 2H), 2.85 (s, 3H), 2.88-2.97 (m, 2H), 3.20-3.27 (m, 2H), 7.36 (brs, 1H).
FAB-MS m / z: 235 (M + 1).

実施例8
実施例6におけるクロロアセトニトリルをブロモアセトニトリルに代え、その他は同様にして反応を行い、4-メチル-1-(メタンスルホニル)ピペリジン-4-アミン 一塩酸塩 一水和物を得た。
1H-NMR(DMSO-d6):1.33(s,3H),1.73-1.77(m,2H),1.81-1.84(m,2H),2.90(s,3H),3.03-3.09(m,2H),3.39-3.45(m,2H),8.33(brs,3H).
ESI-MS m/z:193(M+1).
Example 8
The reaction was conducted in the same manner as in Example 6 except that chloroacetonitrile was replaced with bromoacetonitrile, to give 4-methyl-1- (methanesulfonyl) piperidin-4-amine monohydrochloride monohydrate.
1 H-NMR (DMSO-d 6 ): 1.33 (s, 3H), 1.73-1.77 (m, 2H), 1.81-1.84 (m, 2H), 2.90 (s, 3H), 3.03-3.09 (m, 2H ), 3.39-3.45 (m, 2H), 8.33 (brs, 3H).
ESI-MS m / z: 193 (M + 1).

実施例9
国際公開第WO 2004/009544記載の方法で製造した(2S,4S)-1-(クロロアセチル)-4-フルオロピロリジン-2-カルボニトリル2.00 gにアセトニトリル14 mL、4-メチル-1-(メタンスルホニル)ピペリジン-4-アミン 一塩酸塩 一水和物2.88 g、N-エチルジイソプロピルアミン5.4 mLを加え、80 ℃で14時間加熱撹拌した。溶媒を減圧下留去し、EtOH 14 mLを加え、さらに溶媒を留去した。水2 mL、EtOH 50 mL、N-エチルジイソプロピルアミン0.54 mLを加え加熱溶解し、攪拌下冷却して結晶を析出させた。0 ℃まで冷却し、結晶を濾取し、EtOHで結晶を洗浄した後、減圧乾燥することにより、(2S,4S)-4-フルオロ-1-({[4-メチル-1-(メタンスルホニル)ピペリジン-4-イル]アミノ}アセチル)ピロリジン-2-カルボニトリル3.04 gを白色結晶として得た。
1H-NMR(CDCl3):1.12,1.14(s,3H),1.66(brs,4H),2.26-2.72(m,2H),2.78(s,3H),3.16-4.05(m,6H),3.33(ABq,2H),4.89,4.95(d,1H),5.36,5.44(dt,1H).
FAB-MS m/z:347(M+1).
Example 9
2.00 g of (2S, 4S) -1- (chloroacetyl) -4-fluoropyrrolidine-2-carbonitrile prepared by the method described in International Publication No. WO 2004/009544, 14 mL of acetonitrile, 4-methyl-1- (methane (Sulfonyl) piperidin-4-amine monohydrochloride monohydrate (2.88 g) and N-ethyldiisopropylamine (5.4 mL) were added, and the mixture was heated with stirring at 80 ° C. for 14 hours. The solvent was distilled off under reduced pressure, EtOH 14 mL was added, and the solvent was further distilled off. Water (2 mL), EtOH (50 mL), and N-ethyldiisopropylamine (0.54 mL) were added and dissolved by heating, and the mixture was cooled with stirring to precipitate crystals. After cooling to 0 ° C., the crystals were collected by filtration, washed with EtOH, and then dried under reduced pressure to give (2S, 4S) -4-fluoro-1-({[4-methyl-1- (methanesulfonyl ) Piperidin-4-yl] amino} acetyl) pyrrolidine-2-carbonitrile (3.04 g) was obtained as white crystals.
1 H-NMR (CDCl 3 ): 1.12, 1.14 (s, 3H), 1.66 (brs, 4H), 2.26-2.72 (m, 2H), 2.78 (s, 3H), 3.16-4.05 (m, 6H), 3.33 (ABq, 2H), 4.89, 4.95 (d, 1H), 5.36, 5.44 (dt, 1H).
FAB-MS m / z: 347 (M + 1).

本発明によれば、医薬、殊にDPP-IV阻害剤として有用な化合物A又はその塩の効率的な製造法、特にその製造法を採用した場合の中間体である化合物B又はその塩、及びその製造法が提供される。   According to the present invention, an efficient production method of a compound A or a salt thereof useful as a pharmaceutical, particularly a DPP-IV inhibitor, particularly a compound B or a salt thereof as an intermediate when the production method is employed, and A method for its manufacture is provided.

Claims (4)

式(I)
Figure 2006062063
[式中の記号は、以下の意味を示す。
Ms:メタンスルホニル。
Me:メチル。
R1:-H、ハロゲン又は-OH。]
で示されるピペリジン誘導体又はその塩から、R1を有するアセチル基を脱離させることを含む、式(II)
Figure 2006062063
[式中の記号は、以下の意味を示す。
Ms:メタンスルホニル。
Me:メチル。]
で示される4-アミノピペリジン誘導体又はその塩の製造法。
Formula (I)
Figure 2006062063
[The symbols in the formula have the following meanings.
Ms: Methanesulfonyl.
Me: methyl.
R 1 : —H, halogen or —OH. ]
And removing the acetyl group having R 1 from the piperidine derivative represented by the formula (II) or a salt thereof:
Figure 2006062063
[The symbols in the formula have the following meanings.
Ms: Methanesulfonyl.
Me: methyl. ]
A process for producing a 4-aminopiperidine derivative represented by the formula:
式(I)で示されるピペリジン誘導体又はその塩。
Figure 2006062063
[式中の記号は、以下の意味を示す。
Ms:メタンスルホニル。
Me:メチル。
R1:-H、ハロゲン又は-OH。]
A piperidine derivative represented by the formula (I) or a salt thereof.
Figure 2006062063
[The symbols in the formula have the following meanings.
Ms: Methanesulfonyl.
Me: methyl.
R 1 : —H, halogen or —OH. ]
式(III)
Figure 2006062063
[式中の記号は、以下の意味を示す。
Ms:メタンスルホニル。
Me:メチル。]
で示される4-ヒドロキシピペリジン誘導体又はその塩を用いた、請求項2記載の化合物の製造法。
Formula (III)
Figure 2006062063
[The symbols in the formula have the following meanings.
Ms: Methanesulfonyl.
Me: methyl. ]
The manufacturing method of the compound of Claim 2 using the 4-hydroxy piperidine derivative or its salt shown by these.
請求項1記載の方法で製造された、請求項1記載の式(II)で示される4-アミノピペリジン誘導体又はその塩を用いた、式(IV)
Figure 2006062063
[式中の記号は、以下の意味を示す。
Ms:メタンスルホニル。
Me:メチル。]
で示される2-シアノ-4-フルオロピロリジン誘導体又はその塩の製造法。
A 4-aminopiperidine derivative represented by the formula (II) according to claim 1, which is produced by the method according to claim 1, or a salt thereof,
Figure 2006062063
[The symbols in the formula have the following meanings.
Ms: Methanesulfonyl.
Me: methyl. ]
A process for producing a 2-cyano-4-fluoropyrrolidine derivative represented by the formula:
JP2006546678A 2004-12-08 2005-12-05 Piperidine derivatives and process for producing the same Withdrawn JPWO2006062063A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004355904 2004-12-08
JP2004355904 2004-12-08
PCT/JP2005/022299 WO2006062063A1 (en) 2004-12-08 2005-12-05 Piperidine derivative and process for producing the same

Publications (1)

Publication Number Publication Date
JPWO2006062063A1 true JPWO2006062063A1 (en) 2008-06-12

Family

ID=36577890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006546678A Withdrawn JPWO2006062063A1 (en) 2004-12-08 2005-12-05 Piperidine derivatives and process for producing the same

Country Status (3)

Country Link
JP (1) JPWO2006062063A1 (en)
CA (1) CA2587749A1 (en)
WO (1) WO2006062063A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013007768A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ264634A (en) * 1993-10-11 1995-12-21 Sanofi Sa 1-heteroaryl-4-alkyl-4-amino-piperidines and pharmaceutical compositions thereof and piperidine precursors
FR2760014B1 (en) * 1997-02-27 1999-04-09 Adir NOVEL 2-AMINO INDANE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TW200401635A (en) * 2002-07-23 2004-02-01 Yamanouchi Pharma Co Ltd 2-Cyano-4-fluoropyrrolidine derivative or salt thereof

Also Published As

Publication number Publication date
CA2587749A1 (en) 2006-06-15
WO2006062063A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
ES2437755T3 (en) Intermediates for thienopyrazole derivatives that have PDE 7 inhibitory activity
WO2007058305A1 (en) Process for production of cinnamamide derivative
JP2021536471A (en) Methyl 6- (2,4-dichlorophenyl) -5- [4-[(3S) -1- (3-fluoropropyl) pyrrolidine-3-yl] oxyphenyl] -8,9-dihydro-7H-benzo [7] ] Salt of Annelen-2-carboxylate and its manufacturing method
RU2563630C1 (en) Method of obtaining hydrochloride of 1-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one and intermediate compounds, applied in it
MX2007004216A (en) Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines.
US8716481B2 (en) Process for the preparation of 6-substituted-1-(2H)-isoquinolinones
CA2470236A1 (en) Lactams as tachykinin antagonists
DK2611776T3 (en) Method for producing intermediate for synthesis of drug
JPH0776209B2 (en) Process for producing optically active 3-hydroxypyrrolidine derivative
JPWO2006062063A1 (en) Piperidine derivatives and process for producing the same
JP5017101B2 (en) Preparation of asymmetric tetrasubstituted carbon atom-containing compounds
JP2010526142A5 (en)
MX2007008280A (en) Synthesis of ccr5 receptor antagonists.
KR20090028682A (en) Process for preparing 1-halo-2,7-naphthyridinyl derivatives
JP4031366B2 (en) Amlodipine production method
JP2004091486A5 (en)
JP5073497B2 (en) Process for producing tetra-substituted-5-azaspiro [2.4] heptane derivative and optically active intermediate thereof
JP2008518918A (en) Process for preparing substituted 4-amino-1- (pyridylmethyl) piperidine and related compounds
JP2002537394A (en) Method for producing paroxetine
WO2014069351A1 (en) Method for producing optically active bicyclic urea compound
KR101686087B1 (en) Process for Production of Optically Active Indoline Derivatives or Salts Thereof
US20120115907A1 (en) Novel compounds as inhibitors of renin
WO2013084241A1 (en) Compounds as inhibitors of renin
KR100457496B1 (en) METHOD FOR THE PREPARATION OF 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOLE-3-YL) -1-PIPERIDINYL]ETHYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO[1,2-a]PYRIMIDINE-4-ONE AND INTERMEDIATES FOR IT
JP2005239617A (en) Method for producing 3-cyclopropylaminomethyl-4-fluoropyrrolidine derivative

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20090303